Department of Medicine, Division of General Internal Medicine, Institute for Human Genetics and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, CA 94158, USA.
Carcinogenesis. 2013 Aug;34(8):1787-93. doi: 10.1093/carcin/bgt110. Epub 2013 Apr 4.
Hispanic women in the USA have lower breast cancer incidence than non-Hispanic white (NHW) women. Genetic factors may contribute to this difference. Breast cancer genome-wide association studies (GWAS) conducted in women of European or Asian descent have identified multiple risk variants. We tested the association between 10 previously reported single nucleotide polymorphisms (SNPs) and risk of breast cancer in a sample of 4697 Hispanic and 3077 NHW women recruited as part of three population-based case-control studies of breast cancer. We used stratified logistic regression analyses to compare the associations with different genetic variants in NHWs and Hispanics classified by their proportion of Indigenous American (IA) ancestry. Five of 10 SNPs were statistically significantly associated with breast cancer risk. Three of the five significant variants (rs17157903-RELN, rs7696175-TLR1 and rs13387042-2q35) were associated with risk among Hispanics but not in NHWs. The odds ratio (OR) for the heterozygous at 2q35 was 0.75 [95% confidence interval (CI) = 0.50-1.15] for low IA ancestry and 1.38 (95% CI = 1.04-1.82) for high IA ancestry (P interaction 0.02). The ORs for association at RELN were 0.87 (95% CI = 0.59-1.29) and 1.69 (95% CI = 1.04-2.73), respectively (P interaction 0.03). At the TLR1 locus, the ORs for women homozygous for the rare allele were 0.74 (95% CI = 0.42-1.31) and 1.73 (95% CI = 1.19-2.52) (P interaction 0.03). Our results suggest that the proportion of IA ancestry modifies the magnitude and direction of the association of 3 of the 10 previously reported variants. Genetic ancestry should be considered when assessing risk in women of mixed descent and in studies designed to discover causal mutations.
美国的西班牙裔女性乳腺癌发病率低于非西班牙裔白人(NHW)女性。遗传因素可能促成了这一差异。在欧洲或亚洲血统的女性中进行的乳腺癌全基因组关联研究(GWAS)已经确定了多个风险变异。我们在三个人群为基础的乳腺癌病例对照研究中招募的 4697 名西班牙裔和 3077 名 NHW 女性样本中,测试了 10 个先前报道的单核苷酸多态性(SNP)与乳腺癌风险之间的关联。我们使用分层逻辑回归分析,比较了不同遗传变异在 NHW 人群和按其美洲原住民(IA)血统比例分类的西班牙裔人群中的关联。在 10 个 SNP 中,有 5 个与乳腺癌风险有统计学显著关联。在西班牙裔人群中,这 5 个显著变异中的 3 个(rs17157903-RELN、rs7696175-TLR1 和 rs13387042-2q35)与风险相关,但在 NHW 人群中没有。在低 IA 血统中,杂合子 2q35 的比值比(OR)为 0.75(95%置信区间[CI] = 0.50-1.15),而在高 IA 血统中为 1.38(95% CI = 1.04-1.82)(P 交互作用 0.02)。在 RELN 位点,与罕见等位基因纯合的女性的 OR 分别为 0.87(95% CI = 0.59-1.29)和 1.69(95% CI = 1.04-2.73)(P 交互作用 0.03)。在 TLR1 基因座,携带稀有等位基因的女性纯合子的 OR 分别为 0.74(95% CI = 0.42-1.31)和 1.73(95% CI = 1.19-2.52)(P 交互作用 0.03)。我们的研究结果表明,在 10 个先前报道的变异体中,有 3 个的 IA 血统比例改变了关联的大小和方向。在评估混合血统女性的风险和设计发现因果突变的研究时,应考虑遗传血统。